Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Publication of Project Plans

We are pleased to announce the Project Plans for the deliverables in the EUnetHTA 21 Service Contract (2021-2023) are published. They provide a general overview and describe the objectives, approach and timelines

Read More »

COVID-19 Response

EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.

Services

EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Assessments, Early Dialogues, and Post Launch Evidence Generation (PLEG). Find out more here.

Assessments

Pharmaceutical Joint Assessments (PTJA) and Other Technologies Collaborative Assessments (OTCA) are key EUnetHTA outputs. Find current project status, EUnetHTA Prioritisation List (EPL) and Topic Identification, Selection, and Prioritisation (TISP), uptake data and archived content here.

Tools

EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.

Get Involved

EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.

COVID-19 Response

EUnetHTA has prioritised COVID-19-related initiatives above other work during the current
time. Here you will find updated information and publications relating to COVID-19 diagnostic
testing, therapeutic treatments, and useful links to further data from our network partners.

Services

EUnetHTA develops several services that help inform the decision-making process around the
introduction of pharmaceuticals and other technologies at the national, regional, and
European levels. These include Joint Assessments, Early Dialogues, and Post Launch Evidence
Generation (PLEG). Find out more here.

Assessments

Pharmaceutical Joint Assessments (PTJA) and Other Technologies Collaborative Assessments
(OTCA) are key EUnetHTA outputs. Find current project status, EUnetHTA Prioritisation List
(EPL) and Topic Identification, Selection, and Prioritisation (TISP), uptake data and archived
content here.

Tools

EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint
work process, helping partners to proceed with a defined methodology. Access all current and
archived tools here.

Get Involved

EUnetHTA functions as a collaboration between network members and exterior partners to
develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out
more about partner involvement, activities, and EUnetHTA events here.